-
1
-
-
0016230850
-
Response of Paget's disease to porcine and salmon calcitonins: Effect of long-term treatment
-
De Rose J, Singer F, Avramides A, Flores A. Dziadiw R, Baker RK, Wallach S (1974) Response of Paget's disease to porcine and salmon calcitonins: effect of long-term treatment. Am J Med 56:858-66
-
(1974)
Am J Med
, vol.56
, pp. 858-866
-
-
De Rose, J.1
Singer, F.2
Avramides, A.3
Flores, A.4
Dziadiw, R.5
Baker, R.K.6
Wallach, S.7
-
2
-
-
9044224216
-
Resistance to calcitonin during the treatment of Paget's disease
-
Hosking DJ, Huddlestone LB, Clark AJ, Johnson SK, Martin TJ (1981) Resistance to calcitonin during the treatment of Paget's disease. Bone 2:315-320
-
(1981)
Bone
, vol.2
, pp. 315-320
-
-
Hosking, D.J.1
Huddlestone, L.B.2
Clark, A.J.3
Johnson, S.K.4
Martin, T.J.5
-
3
-
-
0022400813
-
Long-term follow-up of therapy with intermittent etidronate sodium in Paget's disease of bone
-
Altman R (1985) Long-term follow-up of therapy with intermittent etidronate sodium in Paget's disease of bone. Am J Med 79:583-589
-
(1985)
Am J Med
, vol.79
, pp. 583-589
-
-
Altman, R.1
-
4
-
-
0023676509
-
A single infusion of the biphosphonate AHPrBP (APD) in the treatment of Paget's disease of bone
-
Thiebaud D, Jaegar P, Gobelet C, Jacquet AF (1988) A single infusion of the biphosphonate AHPrBP (APD) in the treatment of Paget's disease of bone. Am J Med 85:207-212
-
(1988)
Am J Med
, vol.85
, pp. 207-212
-
-
Thiebaud, D.1
Jaegar, P.2
Gobelet, C.3
Jacquet, A.F.4
-
5
-
-
0026505765
-
Reatment of Paget's disease by weekly infusion of 3-aminohydroxypropylidene-1. 1-bisphosphonate (APD)
-
Ryan PJ, Sherry M, Gibson T, Fogelman I (1992) reatment of Paget's disease by weekly infusion of 3-aminohydroxypropylidene-1. 1-bisphosphonate (APD). Br J Rheumatol 31:97-101
-
(1992)
Br J Rheumatol
, vol.31
, pp. 97-101
-
-
Ryan, P.J.1
Sherry, M.2
Gibson, T.3
Fogelman, I.4
-
6
-
-
0025970833
-
Intravenous aminobisphosphonate in Paget's disease: Clinical, biochemical, histomorphometric and radiological responses
-
Fenton AJ, Gutteridge DH, Kent GN, Price RI, Retallack RW, Bhagat IC, Worth GK, Thompson RI, Watson IG, Barry-Walsh C, Matz LR (1991) Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses. Clin Endocrinol 34:197-204
-
(1991)
Clin Endocrinol
, vol.34
, pp. 197-204
-
-
Fenton, A.J.1
Gutteridge, D.H.2
Kent, G.N.3
Price, R.I.4
Retallack, R.W.5
Bhagat, I.C.6
Worth, G.K.7
Thompson, R.I.8
Watson, I.G.9
Barry-Walsh, C.10
Matz, L.R.11
-
7
-
-
0028202861
-
Perspectives: A practical guide to the use of pamidronate in the treatment of Paget's disease
-
Siris ES (1994) Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease. J Bone Miner Res 9:303-304
-
(1994)
J Bone Miner Res
, vol.9
, pp. 303-304
-
-
Siris, E.S.1
-
9
-
-
0021856456
-
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone
-
Yates AJP, Percival RC, Gray RES, Urwin SH, Preston CJ, Russell RGG, Atkins RM, Hamdy NAT, Beneton MNC, Kanis JA (1985) Intravenous clodronate in the treatment and retreatment of Paget's disease of bone. Lancet 1:474-477
-
(1985)
Lancet
, vol.1
, pp. 474-477
-
-
Yates, A.J.P.1
Percival, R.C.2
Gray, R.E.S.3
Urwin, S.H.4
Preston, C.J.5
Russell, R.G.G.6
Atkins, R.M.7
Hamdy, N.A.T.8
Beneton, M.N.C.9
Kanis, J.A.10
-
10
-
-
0027134776
-
Mineralisation defects with pamidronate therapy for Paget's disease
-
Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF (1993) Mineralisation defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1460
-
(1993)
Lancet
, vol.342
, pp. 1459-1460
-
-
Adamson, B.B.1
Gallacher, S.J.2
Byars, J.3
Ralston, S.H.4
Boyle, I.T.5
Boyce, B.F.6
|